For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Health IT in 2025: Trends, tensions and transition in turbulent times
+News
In print
Health IT in 2025: Trends, tensions and transition in turbulent times
Tuesday 11 March 2025, 11:26 AM

A survey on AI use in general practice found half of practices are now using AI, and at least a quarter report using it daily [Image: everythingpossible on iStock]
What is next for health IT in 2025? Reporter Stephen Forbes talks to four folk from the sector about the growth areas – and potential flashpoints – shaping the year ahead
Essentials
AI use in general practice is increasing rapidly. Experts emphasise the need for best practices and transparency rather than increase, READ MORE
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.